Overview
Robert Mccroskey is a Hematologist Oncology specialist and an Oncologist in Kent, Washington. Dr. Mccroskey is rated as an Experienced provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Multiple Myeloma, Familial Colorectal Cancer, Non-Hodgkin Lymphoma, and Familial Prostate Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
222 State Ave N, Kent, WA 98030
1624 S I St, Tacoma, WA 98405
Additional Areas of Focus
Dr. Mccroskey has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Northwest Medical Specialties PLLC
Ndegwa Njuguna is a Hematologist Oncology specialist and a Hematologist in Federal Way, Washington. Dr. Njuguna is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Dehydration, Chronic B-Cell Leukemia (CBCL), Pleuropulmonary Blastoma, and Acute Mountain Sickness. Dr. Njuguna is currently accepting new patients.
The Association Of University Physicians
Prakash Vishnu is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Vishnu is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Bone Marrow Aspiration. Dr. Vishnu is currently accepting new patients.
American Oncology Partners PA
Ahmad Fora is an Oncologist and a Hematologist Oncology provider in Olympia, Washington. Dr. Fora is rated as an Advanced provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Essential Thrombocythemia, Thrombocytopenia, Acute Mountain Sickness, and Schnitzler Syndrome. Dr. Fora is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Mccroskey isDistinguished. Learn about Multiple Myeloma.
- Advanced
- AgranulocytosisDr. Mccroskey isAdvanced. Learn about Agranulocytosis.
- Chronic Familial NeutropeniaDr. Mccroskey isAdvanced. Learn about Chronic Familial Neutropenia.
- DehydrationDr. Mccroskey isAdvanced. Learn about Dehydration.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Mccroskey isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- End-Stage Renal Disease (ESRD)Dr. Mccroskey isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Familial Colorectal CancerDr. Mccroskey isAdvanced. Learn about Familial Colorectal Cancer.
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Mccroskey isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Mccroskey isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Mccroskey isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Mccroskey isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Mccroskey isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.